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Abstract 
Background: How host cell glycosylation affects EPEC or EHEC O157:H7 invasion is unclear. This study investigated 
whether and how O-glycans were involved in EPEC or EHEC O157:H7 invasion into HT-29 cells.
Results: Lectin histochemical staining confirmed stronger staining with PNA, which labeled Galβ1, 3 GalNAc (core 
1 structure) in HT-29-Gal-OBN and C2GnT2-sh2/HT-29 cells, compared with control cells. EPEC or EHEC O157:H7 
invasion into HT-29 and its derived cells was based on the intracellular presence of GFP-labeled bacteria. The dif-
ferentiation of HT-29 cells led to a reduction in EPEC internalization compared with HT-29 cells (p < 0.01). EPEC or 
EHEC O157:H7 invasion into HT-29-OBN and HT-29-Gal-OBN cells increased compared with HT-29 and HT-29-Gal cells 
(p < 0.05 and p < 0.01). Core 2 O-glycan-deficient HT-29 cells underwent a significant increase in EPEC (p < 0.01) or 
EHEC O157:H7 (p < 0.05) invasion compared with control cells.
Methods: Bacterial invasion into cultured cells was determined by a gentamicin protection assay and a GFP-labeled 
bacteria invasion assay. O-glycans biosynthesis was inhibited by benzyl-α-GalNAc, and core 2 O-glycan-deficient 
HT-29 cells were induced by C2GnT2 interference.
Conclusion: These data indicated that EPEC or EHEC O157:H7 invasion into HT-29 cells was related to their O-glyco-
sylation status. This study provided the first evidence of carbohydrate-dependent EPEC or EHEC O157:H7 invasion into 
host cells.
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Background
The mucin layer functions as a barrier to gastrointestinal 
tract (GI) bacterial infection, effectively hampering bacte-
ria from adhering to and invading into cells [1, 2]. Mucin-
type O-glycans are classified into eight major groups 
(cores 1–8) based on their different carbohydrate resi-
dues [1]. Mucin-type core 2 O-glycan is biosynthesized 
by the enzyme core 2 β1, 6-N-acetylglucosaminyltrans-
ferase 2 (C2GnT2) (Fig. 1), which is mainly expressed in 
the colon [3, 4].
Enteropathogenic E. coli (EPEC) and Enterohem-
orrhagic E. coli O157:H7 (EHEC O157:H7) cause ill-
nesses from mild diarrhea to severe diseases, such as 
hemorrhagic colitis [5]. O-glycans might be related to 
the selection of the commensal flora in the distal colon, 
and it could act as an attachment site for different bac-
teria [6]. We have reported that core 2 O-glycan defi-
ciency in HT-29 cells and enhanced MUC3 expression 
in HT-29-Gal cells resulted in decreased EPEC or EHEC 
O157:H7 adherence [7, 8].
A sub-population of EPEC or EHEC O157:H7 is able to 
enter cultured intestinal epithelial cells [9–12]. Intimate 
attachment and invasion by EPEC and EHEC O157:H7 
are both mediated by a 94-kDa intimin, which is encoded 
by the eae gene [13]. There is a strong dependence on 
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microfilaments, depolymerization of microtubules and 
receptor-mediated endocytosis in the uptake of EPEC or 
EHEC O157:H7 by intestinal epithelial cells, suggesting 
that bacterial invasion requires both bacterial and eukar-
yotic protein syntheses [10].
To invade the epithelium, microbes commonly inter-
act with glycan structures of the host glycocalyx [14, 15]. 
Both EPEC and EHEC O157:H7 can bind the intestinal 
mucin and the glycosylated mucin, which are recycled 
between the plasma membrane and the trans-Golgi net-
work (TGN) or Golgi complex [16]. It is possible that 
recycling of the glycosylated mucin results in internali-
zation of the binding EPEC or EHEC O157:H7. This fact 
inspired us to investigate whether mucin-type O-glycans 
are involved in EPEC or EHEC O157:H7 internalization 
in intestinal epithelial cells. We identified the O-gly-
cosylation status of HT-29-OBN cells and mucin-type 
core 2 O-glycan deficient HT-29 cells, using a series of 
lectin recognition: Maackia amurensis (MAA), Arachis 
hypogaea (PNA), Dolichos biflorus (DBA), Ulex euro-
paeus (UEA-I), Griffonia simplicifolia (GSAII), Canavalia 
ensiformis (ConA), and Sambucus nigra (SNA), and we 
further demonstrated that core 2 mucin-type O-glycan 
inhibited EPEC or EHEC O157:H7 invasion into HT-29 
cells.
Results
Benzyl‑α‑GalNAc‑treated HT‑29 or HT‑29‑Gal cells altered 
their O‑glycosylation status
To confirm whether altered O-glycosylation occurred in 
HT-29-Gal, HT-29-OBN and HT-29-Gal-OBN cells [7], 
lectin histochemistry was performed using FITC-labeled 
MAA, PNA, DBA, UEA-I, GSAII or ConA. As shown 
in Fig. 2, similar lectin staining was found in HT-29 and 
HT-29-OBN cells. MAA, PNA, DBA and GSAII his-
tochemical staining of HT-29-Gal cells was lower than 
that of HT-29 cells, indicating lower α-(2,3)-linked sialic 
acid terminated, core 1, GalNAc terminated and Glc-
NAc terminated structures in HT-29-Gal cells. PNA was 
increased, and MAA was reduced in HT-29-Gal-OBN 
cells compared to HT-29-Gal cells, indicating more core 
1 structures and lower α-(2,3)-linked sialic acid-termi-
nated structures (lower MAA staining) in HT-29-Gal-
OBN cells. The spherical alignment of the HT-29-Gal and 
HT-29-Gal-OBN cells indicated that they possessed the 
differentiated phenotype.
Fig. 1 Illustration of mucin-type O-glycan synthesis. Starting from N-acetylgalactosamine (GalNAc) on serine or threonine residues in a poly-
peptide, core 1 synthase (C1GnT) transfers galactose to make the Core 1 structure Galβ1 → 3GalNAcα1 → Ser/Thr, and core 3 synthase (C3GnT) 
transfers N-acetylglucosamine to form a core 3 structure GlcNAcβ1 → 3GalNAcα1 → Ser/Thr (Core 3). Core 1 is converted to Core 2 by C2GnT-1, 
C2GnT-2, and C2GnT-3. Core 3 is converted to Core 4 by C2GnT-2. Mannose, fucose, glucose and GlcNAc are directly linked to Ser/Thr, and they form 
core 5-8 structures
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Direct evidence of GFP‑labeled EPEC or EHEC O157:H7 
invasion into intestinal epithelial cells
To confirm whether EPEC or EHEC O157:H7 could 
invade into HT-29, HT-29-OBN, HT-29-Gal, or HT-
29-Gal-OBN cells, bacterial invasion experiments using 
GFP-labeled EPEC or EHEC O157:H7 in HT-29-Gal, 
HT-29-Gal-OBN, HT-29 or HT-29-OBN cells were 
observed under a confocal microscope after co-culturing 
with GFP-labeled bacteria and tissue cells and further 
gentamicin treatment. As shown in Fig.  3, the major-
ity of GFP-labeled EPEC or EHEC O157:H7 was exactly 
located in the cytoplasm of some of the bacteria-infected 
HT-29, HT-29-OBN, HT-29-Gal, and HT-29-Gal-OBN 
cells, although some of the adherent GFP-labeled EPEC 
or EHEC O157:H7 was located on the cell surface (indi-
cated by arrowhead). However, it was difficult to quan-
tify the amount of internalized bacteria according to the 
green fluorescence-labeled bacteria using the confocal 
microscope. The traditional bacteria invasion assay was 
further used to quantify the internalized bacteria.
HT‑29 cell differentiation was related to EPEC or EHEC 
O157:H7 invasion
A traditional gentamicin invasion assay was used to 
quantify the numbers of invaded bacteria within the 
HT-29, HT-29-OBN, HT-29-Gal, or HT-29-Gal-OBN 
cells. Because the traditional gentamicin invasion assay 
requires bacterial sensitivity to gentamicin, the EPEC 
E2348/69 strain (serotype: O157:H7) (EPEC) and EHEC 
Sakai stain (serotype: O157:H7) (EHEC O157:H7) used 
in this study were checked for the susceptibility/resist-
ance pattern of gentamicin, and neither of the bacteria 
could survive in 100  μg/ml gentamicin containing cell 
culture medium or could grow in 100 μg/ml gentamicin 
containing MacConkey agar with overnight incubation 
at 37 °C.
Fig. 2 Lectin histochemical staining in HT-29, HT-29-OBN, HT-29-Gal, and HT-29-Gal-OBN cells. HT-29, HT-29-OBN, HT-29-Gal, or HT-29-Gal-OBN cells 
were stained with FITC-labeled MAA, PNA, DBA, UEA-I, GSAII or ConA lectins and were observed under fluorescence microscopy. ×40 objective
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The number of EPEC bacteria that invaded into dif-
ferentiated HT-29-Gal cells (61  ±  8) was significantly 
lower than that of EPEC bacteria invading into undif-
ferentiated HT-29 cells (198 ± 25 CFU) (p < 0.01); the 
number of EHEC O157:H7 bacteria that invaded into 
differentiated HT-29-Gal cells (80 ± 7 CFU) was simi-
lar with that of EHEC O157:H7 bacteria invading into 
undifferentiated HT-29 cells (90  ±  10  CFU) (Fig.  4). 
The results indicated that the differentiation of HT-29 
cells affected the amount of EPEC invasion into HT-29 
cells, but it did not affect EHEC O157:H7 bacteria 
invasion.
EPEC or EHEC O157:H7 invasion increased after the 
abrogation of O‑glycan biosynthesis
The traditional bacteria invasion assay showed that 
the number of EPEC bacteria that invaded into the 
HT-29-Gal-OBN cells was 99 ±  9  CFU, which was sig-
nificantly higher than the number that invaded the HT-
29-Gal cells (61 ± 8) (p < 0.05), and the number of EHEC 
bacteria that invaded the HT-29-Gal-OBN cells was 
131 ±  11  CFU, which was significantly higher than the 
number that invaded the HT-29-Gal cells (80 ± 7 CFU) 
(p  <  0.01). The number of EPEC bacteria that invaded 
into the HT-29-OBN cells was 240  ±  19  CFU, which 
was significantly higher than the number that invaded 
the HT-29 cells (198 ± 25 CFU) (p < 0.05), and the num-
ber of EHEC bacteria that invaded into the HT-29-OBN 
cells was 160 ±  15  CFU, which was significantly higher 
than the number that invaded the HT-29-Gal cells 
(90  ±  10  CFU) (p  <  0.01) (Fig.  4). These results indi-
cated that the abrogation of O-glycan biosynthesis in the 
Fig. 3 Identification of bacterial invasion with GFP-labeled EPEC or EHEC O157:H7. The internalized GFP-labeled EPEC or GFP-labeled EHEC O157:H7 
within HT-29, HT-29-OBN, HT-29-Gal, or HT-29-Gal-OBN cells was observed under a confocal microscope after co-culturing with GFP-labeled bacte-
ria and tissue cells and further gentamicin treatment. The internalized bacteria were confirmed based on the presence of green fluorescence within 
the bacteria-infected cells. ×63 objective
Fig. 4 Comparison of EPEC or EHEC O157:H7 invasion into HT-29, HT-
29-OBN, HT-29-Gal, and HT-29-Gal-OBN cells using bacteria invasion 
assay. HT-29, HT-29-OBN, HT-29-Gal, and HT-29-Gal-OBN cells were 
incubated with EPEC or EHEC O157:H7, the adherent bacteria were 
removed by gentamicin, and the internalized EPEC or EHEC O157:H7 
within the different cells was quantified by determining the CFU 
following by the plating of serial dilutions of the bacteria on Mac-
Conkey agar with overnight incubation at 37 °C. Asterisk represents 
a significant difference (p < 0.05), double asterisk represents a highly 
significant difference (p < 0.01)
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HT-29-Gal cells and HT-29 cells was beneficial for EPEC 
or EHEC O157:H7 invasion into cells.
To exclude the possibility in which the alteration of 
EPEC or EHEC O157:H7 invasion into the differenti-
ated HT-29 cells and O-glycan biosynthesis inhibition of 
HT-29 cells was caused by their apoptosis, we performed 
apoptosis experiments (TUNEL assay) in HT-29, HT-
29-Gal, HT-29-OBN and HT-29-Gal-OBN cells [7], and 
we found no significant difference in the apoptosis index 
among HT-29 (2.4 ± 0.3), HT-29-OBN (2.9 ± 0.7), HT-
29-Gal (2.5 ± 0.8) and HT-29-Gal-OBN (1.8 ± 0.7) cells. 
Thus, the similarity of the apoptosis index among HT-29, 
HT-29-OBN, HT-29-Gal and HT-29-Gal-OBN cells indi-
cated that the differentiation and the inhibition of O-gly-
cosylation due to benzyl-α-GalNAc treatment in HT-29 
cells did not cause their apoptosis compared with HT-29 
cells, and the alteration of EPEC or EHEC O157:H7 inva-
sion into the differentiated HT-29 cells and O-glycan bio-
synthesis inhibition of HT-29 cells were not caused by 
their apoptosis.
C2GnT2‑deficient HT‑29 cells altered their O‑glycosylation 
status
To determine whether O-glycosylation status was altered 
in C2GnT2-deficient HT-29 cells, we chose biotin-labeled 
MAA, PNA or SNA to perform lectin histochemistry 
in HT-29, shRNA-Ctr/HT-29 and C2GnT2-sh2/HT-29 
cells. MAA and SNA staining of the C2GnT2-sh2/HT-29 
cells was similar to that of the HT-29 and shRNA-Ctr/
HT-29 cells. PNA staining in the C2GnT2-sh2/HT-29 
cells was significantly stronger than in the HT-29 and 
shRNA-Ctr/HT-29 cells (Fig.  5). Because PNA specifi-
cally binds to Galβ1,3GalNAc, which are O-glycan core 
1 structures, it was consistent with the speculation that 
the O-glycan core 1 structure would be exposed due to 
the inhibition of O-glycan core 2 synthesis in C2GnT2-
deficient HT-29 cells.
C2GnT2‑deficient HT‑29 cells had more bacteria invasion
HT-29, shRNA-Ctr/HT-29 and C2GnT2-sh2/HT-29 
cells were used in a bacterial invasion assay. As shown in 
Fig.  6, 79 ±  25 and 58 ±  22  CFU of EPEC invaded the 
HT-29 and shRNA-Ctr/HT-29 cells, respectively, and 
167 ± 36 CFU of EPEC invaded the C2GnT2-sh2/HT-29 
cells. More EPEC invaded into the C2GnT2-sh2/HT-29 
cells than into the HT-29 and shRNA-Ctr/HT-29 cells 
(p < 0.01). In addition, 76 ± 14 and 70 ± 18 CFU of EHEC 
O157:H7 invaded into the HT-29 and shRNA-Ctr/HT-29 
cells, respectively, and 107 ± 32 CFU of EHEC O157:H7 
invaded into the C2GnT2-sh2/HT-29 cells. More EHEC 
O157:H7 invaded into the C2GnT2-sh2/HT-29 cells than 
into the HT-29 and shRNA-Ctr/HT-29 cells (p  <  0.05). 
These results indicated that EPEC or EHEC O157:H7 
invasion into human HT-29 cells was related to the 
mucin-type core 2 O-glycan present in HT-29 cells.
Taken together, EPEC or EHEC O157:H7 invasion into 
HT-29 cells was related to their O-glycosylation status 
and differentiated stage; in particular, mucin-type core 
2 O-glycan inhibited EPEC or EHEC O157:H7 invasion 
into HT-29 epithelial cells.
Discussion
The internalization of EPEC or EHEC O157:H7 into 
cultured intestinal epithelial cells has been recognized 
with clear evidence. We confirmed here that mucin-type 
core 2 O-glycan might be one of the pivotal structures of 
O-glycosylated chains as protection mechanisms against 
EPEC or EHEC O157:H7 invasion.
EPEC intimin protein, type III secretion apparatus, 
EHEC O157:H7 CsgA and Lpp proteins and Curli fib-
ers affect EPEC or EHEC O157:H7 internalization into 
eukaryotic cells [11, 17, 18]. Eukaryotic cells exert their 
own structural changes to adapt to EPEC or EHEC 
O157:H7 invasion. These cells belong to the “attach-
ing and effacing (A/E) pathogen” category because of 
their ability to induce A/E lesions on intestinal epithe-
lial cells; A/E lesions include localized effacement of the 
brush border microvilli, intimate bacterial attachment to 
the host epithelium, and the formation of cytoskeleton-
rich pedestal structures beneath the adherent bacteria 
[19]. Intracellular EHEC O157:H7 were confirmed to be 
within membrane-bounded vacuoles by electron micros-
copy, EHEC O157:H7 invasion was dependent on eukar-
yotic microfilament assembly [20]. The effector EspT 
facilitated EPEC internalization into non-phagocytic cells 
in a process involving Rac1 and Wave2, which form intra-
cellular actin pedestals [21].
Two useful models of bacterial invasion into eukary-
otic cells are Pseudomonas aeruginosa and Campylobac-
ter jejuni. Neuraminidase-1 (NEU-1)-dependent MUC1 
ectodomain desialylation increased Pseudomonas aerugi-
nosa invasion of airway epithelium [22]. Purified chicken 
intestinal  mucin attenuated the adherence and invasion 
of Campylobacter jejuni in human HCT-8 cells in vitro, 
and this effect was attributed to mucin O-glycosylation 
[23]. Campylobacter jejuni invasion into HCT-8 cells 
was a glycan-mediated effect [24]. Crude human mucus 
tended to enhance Campylobacter jejuni binding and 
internalization [25].
EHEC O157:H7 invasion into human epithelial cells is 
known to be involved in some structures and processes 
of eukaryotic cells [10, 26]. The novel possibility of recy-
cling-associated O-glycan processing from Gal1-4Glc-
NAc1-6(Gal1-3)GalNAc (core 2) to Gal1-3GalNAc (core 
1) was found during the recycling of MUC1 [27]. Involve-
ment of O-glycosylation in the intracellular trafficking of 
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glycoproteins was found in polarized intestinal epithelial 
cells [28]. Using cell surface biotinylation and subcel-
lular fractionation, increased accumulation of plasma 
membrane protein was found in endosomes after C1galt1 
depletion. Confocal laser scanning microscopy and fluor-
imetry revealed increased translocation of negatively 
Fig. 5 Lectin histochemical staining in HT-29, shRNA-Ctr/HT-29 and shRNA- C2GnT2/HT-29 cells. a HT-29, shRNA-Ctr/HT-29 and shRNA-C2GnT2/
HT-29 cells were stained with the biotinylated MAA, PNA or SNA lectins and observed under light microscopy. b Analysis of average optical intensity 
of lectin staining (biotinylated MAA, PNA or SNA lectins) in HT-29, shRNA-Ctr/HT-29 or shRNA-C2GnT2/HT-29 cells. Scale bars 200 μm
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charged fluorescent nanospheres after C1galt1 knock-
down, sustained by an active transport process [29]. Inva-
sion of locus of enterocyte effacement (LEE)-positive and 
LEE-negative strains was higher for human enterocytic 
cell lines and for undifferentiated Caco-2 cells. Intracel-
lular bacteria could be detected as early as 5  min after 
infection. Shiga toxin-producing Escherichia coli (STEC) 
invasion depended on actin microfilaments and protein 
kinases. Disruption of the tight junction occurred by 
EGTA-enhanced invasion of Caco-2 monolayers, and 
bacterial invasion mostly proceeded through the baso-
lateral pole of enterocytes [30]. Pretreatment of HCT-8 
cells with either the cholesterol-depleting agent methyl-
β-cyclodextrin (MβCD) or the tyrosine kinase inhibi-
tor genistein significantly decreased invasion by 98NK2, 
indicating a potential role for lipid rafts in the invasion 
mechanism [31]. The effect of hmLF glycosylation was 
examined for the protein’s ability to affect bacterial bind-
ing to epithelial cells. hmLF significantly inhibited patho-
gen adhesion, and purified hmLF glycans significantly 
reduced Salmonella invasion of colonic epithelial cells to 
levels associated with non-invasive deletion mutations 
[32].
The invasion of EPEC or EHEC O157:H7 into HT-29 
and their derived cells definitely occurred, but the mech-
anism of this invasion is largely unclear, especially the 
greater bacterial invasion into O-glycosylation synthe-
sis-inhibited HT-29 cells and core 2 O-glycan-deficient 
HT-29 cells. These data suggested that the biosynthesis 
of O-glycans residing on mucins was protective against 
EPEC or EHEC O157:H7 invasion into cells. In particular, 
in our study, we observed their invasive ability in O-gly-
can-abrogated HT-29 cells and core 2 mucin-type O-gly-
can-deficient HT-29 cells and found that EPEC or EHEC 
O157:H7 bacteria that invaded into intestinal epithe-
lial cells were significantly increased. This finding might 
be explained by the ability of EPEC or EHEC O157:H7 
to penetrate O-glycan-deficient HT-29 cells based on 
results from O-glycan-deficient HT-29 cells that had no 
attachment receptors for EPEC or EHEC O157:H7 adher-
ence [7] and that lacked a protection barrier for intesti-
nal epithelial cells; thus, the bacteria easily penetrated 
into the target cells. Although no reports in the literature 
have revealed that O-glycan is related to EPEC or EHEC 
O157:H7 invasion into intestinal epithelial cells, glyco-
sylation changes are believed to play important roles in 
susceptibility to urinary tract infection and invasion of 
uropathogenic E. coli [33], and loss of core 1-, core 2- or 
core 3-derived O-glycans in animal models caused spon-
taneous colitis in mice [4, 34]. Further, evidence indicated 
that EHEC O157:H7 binds to isolated human mucus [35].
Conclusions
Our present data confirmed that EPEC or EHEC 
O157:H7 invasion into HT-29 cells was related to their 
O-glycosylation status, and mucin-type core 2 O-gly-
can in HT-29 epithelial cells might be one of the piv-
otal structures of O-glycosylated chains as protection 
mechanisms against EPEC or EHEC O157:H7 invasion. 
This study provided the first evidence of carbohydrate-
dependent EPEC or EHEC O157:H7 invasion into host 
cells and the concepts toward the design of carbohydrate-
dependent inhibition of EPEC and EHEC O157:H7 inva-
sion into human intestinal epithelial cells.
Methods
Materials and cell lines
EPEC E2348/69 strain (serotype: O157:H7) (EPEC) and 
EHEC Sakai stain (serotype: O157:H7) (EHEC O157:H7), 
benzyl-α-GalNAc, and HT-29, HT-29-Gal, HT-29-OBN, 
HT-29-Gal-OBN, C2GnT2-sh2/HT-29 and shRNA-Ctr/
HT-29 cells were described previously [7].
Lectin histochemistry
Coverslips with different cells were fixed with 4 % para-
formaldehyde, rinsed with PBS several times and incu-
bated with 0.3  % H2O2 in PBS for 30  min to block 
endogenous peroxidase activity. After incubation with 
one of the six different FITC-conjugated lectins (PNA, 
MAA, DBA, UEA-I, GSAII and ConA) at the concentra-
tion of 20 μg/ml or the three different biotinylated lectins 
Fig. 6 Comparison of EPEC or EHEC O157:H7 invasion into HT-29, 
shRNA-Ctr/HT-29 and shRNA-C2GnT2/HT-29 cells using bacteria inva-
sion assay. HT-29, shRNA-Ctr/HT-29 and shRNA-C2GnT2/HT-29 cells 
were incubated with EPEC or EHEC O157:H7, the adherent bacteria 
were removed by gentamicin, and the internalized EPEC or EHEC 
O157:H7 within the different cells was quantified by determining 
their CFU. Asterisk represents a significant difference (p < 0.05), double 
asterisk represents a highly significant difference (p < 0.01)
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(MAA, PNA, and SNA) at the concentration of 15 μg/ml 
for 12–14  h at room temperature (all lectins were pur-
chased from Vector Laboratories), the coverslips were 
washed three times in PBS, followed by incubation with 
ABC (Vector Laboratories) for 60 min and washing again 
three times with PBS. The lectin binding site was visual-
ized by incubating the slides with 0.05 M Tris–HCl buffer 
(pH 7.5) containing 0.08 % diaminobenzidine (DAB) and 
0.003 % H2O2. The coverslips were lightly counterstained 
with hematoxylin and were examined using light micros-
copy. The cells stained with different FITC-conjugated 
lectins at the concentration of 20 μg/ml for 1 h at room 
temperature and counterstained with 50 µl DAPI (1:2000 
in PBS) solution for 2  min at room temperature were 
directly observed with a Zeiss LSM 780 confocal micro-
scope under sequential mode to avoid crosstalk, using a 
40× objective, a 1.2 NA oil immersion objective and an 
Ar ion and HeNe lasers (488 nm excitation). The confo-
cal image acquisition was performed so that all samples 
were imaged using consistent settings for laser power and 
detector gain.
Bacteria invasion assay
HT-29-Gal, HT-29-Gal-OBN, HT-29, shRNA-Ctr/HT-29 
and C2GnT-2-sh2/HT-29 cells were seeded and grown 
in different tissue culture media in 24-well tissue culture 
plates until confluent monolayers formed [7]. The cells 
were washed three times with sterilized PBS (pH 7.4) 
and then were cultured in an antibiotic-free cell culture 
medium for 2 h. After co-culturing with a range of EPEC 
or EHEC O157:H7 (105, 106, and 107 CFU/0.1  mL PBS, 
pH 7.4)for 2 h at 37 °C, with at a multiplicity of infection 
(MOI) of 5:1-20:1, and washing with pre-chilled and ster-
ilized PBS (pH 7.4) three times, the cells were cultured 
in 100 μg/ml gentamicin containing cell culture medium 
for 2  h to kill the bacteria that were adherent to ecto-
intestinal epithelial cells. The cells were then washed with 
pre-chilled and sterilized PBS (pH 7.4) three times for 
5 min per wash. The bacteria, which were released from 
inside the intestinal epithelial cells with 200  μl 0.25  % 
trypsin and 0.025 % Triton X-100 per well to rupture the 
cells, and they were quantified by determining the colony 
forming units (CFU) following the plating of serial dilu-
tions of the bacteria on MacConkey agar with overnight 
incubation at 37 °C [36].
Identification of bacterial invasion with GFP‑labeled EPEC 
or EHEC O157:H7
The stably transformed EPEC or EHEC O157:H7 bacte-
ria with the prokaryotic pGFP plasmid were selected with 
150  μg/ml ampicillin (defined as GFP-labeled EPEC or 
EHEC) and were confirmed to emit green fluorescence 
under fluorescence microscopy, as reported previously 
[14]. The bacterial invasion experiments were performed, 
using GFP-labeled EPEC or GFP-labeled EHEC O157:H7 
in HT-29-Gal; the HT-29-Gal-OBN, HT-29 or HT-
29-OBN tissue culture filters housing the epithelial cell 
monolayers were then carefully detached from their 
support and mounted on coverslips, and the coverslips 
were then washed three times with PBS and fixed with 
4  % paraformaldehyde for 30  min after co-culturing 
with GFP-labeled bacteria and tissue cells and further 
gentamicin treatment. They were then further analyzed 
with a Zeiss LSM 780 confocal microscope in sequen-
tial mode to avoid crosstalk between channels, with a 1.2 
NA oil immersion objective and Ar ion and HeNe lasers 
(488 nm excitation). The confocal image acquisition was 
performed so that all samples were imaged using consist-
ent settings for laser power and detector gain.
Statistical analysis
The data are expressed as the mean ± standard deviation 
and were estimated by Student’s t test. All differences 
were deemed significant when p < 0.05 and very signifi-
cant when p < 0.01.
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